SEC-RPT-Panel / raw /aaer /2002 /AAER-1497.txt
codewithdark's picture
Add files using upload-large-folder tool
8802b75 verified
Raw History Blame Contribute Delete
29.7 kB
SEC.gov | William P. Trainor, Vincent D. Celentano, Medical Diagnostic Products, Inc. (f/k/a Novatek International, Inc., Karen Losordo, Diane M. Trainor, Daniel J. Trainor, Geraldine Trainor and Mary N. Celentano !function(){var e=navigator.userAgent,a=document.documentElement,n=a.className;n=n.replace("no-js","js"),/iPad|iPhone|iPod/.test(e)&&!window.MSStream&&(n+=" ua-ios"),a.className=n}(); {"path":{"baseUrl":"\/","pathPrefix":"","currentPath":"node\/487096","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en"},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"gtag":{"tagId":"","consentMode":false,"otherIds":[],"events":[],"additionalConfigInfo":[]},"ajaxPageState":{"libraries":"eJxdT0GOwzAI_JBdn_oei2DkeINNZLC22devlaZS2wtiBhhmcKNUTPo97jxyaXEH3GJpiZrFhQW38A4cMqgeYQGlV19JFTKpQ-kUmvQKXP7I0cO4tC2kPnbg2wVdFslM0SCHPMs3vsEPPD7J6hgOGdPCKJyoRxxqUuePHjLLAuzVjimenRJGSLW08NoBK9LUn6SHlrytVOlcpJShB63QLSpBx_WkOzHNePol4fRQo_qMPvQ36ZXsAmd99lMNr2t_GUR9n60EyX9a_wePd5ns","theme":"uswds_sec","theme_token":null},"ajaxTrustedUrl":[],"gtm":{"tagId":null,"settings":{"data_layer":"dataLayer","include_classes":false,"allowlist_classes":"","blocklist_classes":"","include_environment":false,"environment_id":"","environment_token":""},"tagIds":["GTM-TD3BKV"]},"data":{"extlink":{"extTarget":false,"extTargetAppendNewWindowDisplay":true,"extTargetAppendNewWindowLabel":"(opens in a new window)","extTargetNoOverride":false,"extNofollow":false,"extTitleNoOverride":false,"extNoreferrer":false,"extFollowNoOverride":false,"extClass":"0","extLabel":"(link is external)","extImgClass":false,"extSubdomains":true,"extExclude":".*\\.gov|http:\/\/www.xbrl.org\/utr\/2013-05-17\/utr.xml|http:\/\/www.xbrl.org\/dtr\/type\/numeric-2009-12-16.xsd|http:\/\/www.xbrl.org\/dtr\/type\/nonNumeric-2009-12-16.xsd|https:\/\/secir.secure.force.com\/ombudsman\/OMMSForm","extInclude":"","extCssExclude":".data-exempt","extCssInclude":"","extCssExplicit":"","extAlert":true,"extAlertText":"You are now leaving the SEC Website. The link you have selected is located on another server. Please click on the OK button below to proceed to the selected site. The SEC does not endorse this web site, its sponsor, or any of the policies, activities, products, or services offered on the site or by any advertiser on the site.","extHideIcons":false,"mailtoClass":"0","telClass":"","mailtoLabel":"(link sends email)","telLabel":"(link is a phone number)","extUseFontAwesome":false,"extIconPlacement":"append","extPreventOrphan":false,"extFaLinkClasses":"fa fa-external-link","extFaMailtoClasses":"fa fa-envelope-o","extAdditionalLinkClasses":"","extAdditionalMailtoClasses":"","extAdditionalTelClasses":"","extFaTelClasses":"fa fa-phone","allowedDomains":null,"extExcludeNoreferrer":""}},"user":{"uid":0,"permissionsHash":"e506dfd1572f94bd1f339f1a7483bfbded31d4a9d2bdfdca3fdbc235153380ee"}} Skip to search field Skip to main content An official website of the United States government Here’s how you know Here’s how you know Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. SEC homepage Menu Close Search SEC.gov & EDGAR Search Search Filings Search Filings Full Text Search Latest Filings Mutual Fund Search Variable Insurance Products Search SIC Codes CIK Lookup Public Dissemination Service (PDS) Search Assistance Submit Filings Submit Filings EDGAR Filer Management Portal EDGAR Filing Portal Online Forms Management Portal EDGAR Next Forms Index Filer Support & Resources Data & Research Data & Research Data Library Statistics & Data Visualizations Structured Data Investment Management Data Open Data at the SEC Rules, Enforcement, & Compliance Rules & Regulations Rulemaking Activity Submit Public Comments Staff Guidance No-Action, Interpretive, and Exemptive Letters Self-Regulatory Organization Rulemaking Public Petitions for Rulemaking Enforcement & Litigation Litigation Releases Administrative Proceedings Administrative Law Judge Orders and Initial Decisions Trading Suspensions Distributions to Harmed Investors Receiverships Compliance Examination Priorities Risk Alerts Compliance Outreach Program Proposed Rules What's New Whistleblower Program Featured Topics Featured Topics Crypto Task Force Cybersecurity Market Structure Analytics Saving and Investing for Military Personnel Saving and Investing for Teachers SEC-CFTC Harmonization Initiative Treasury Clearing Implementation About About Mission Commissioners Divisions & Offices Division & Office Directors Advisory Committees Budget & Performance Reports & Publications Commission Votes Contact the SEC Careers Submit a Tip or Complaint Newsroom | Investors Small Businesses Whistleblowers Newsroom | Investors Small Businesses Whistleblowers Search SEC.gov & EDGAR Search More in this Section Enforcement & Litigation Litigation Releases Administrative Proceedings Administrative Law Judge Orders and Initial Decisions Trading Suspensions Distributions to Harmed Investors Receiverships Electronic Filings in Administrative Proceedings (eFAP) Rules of Practice Applications for Reentry Reports of Investigations Whistleblower Program Public Alert: Unregistered Soliciting Entities (PAUSE) SEC Action Lookup - Individuals (SALI) Enforcement Data Delivery Standards Small Businesses Appellate Briefs Amicus / Friend of the Court Briefs Enforcement & Litigation Litigation Releases Administrative Proceedings Administrative Law Judge Orders and Initial Decisions Trading Suspensions Distributions to Harmed Investors Receiverships Electronic Filings in Administrative Proceedings (eFAP) Rules of Practice Applications for Reentry Reports of Investigations Whistleblower Program Public Alert: Unregistered Soliciting Entities (PAUSE) SEC Action Lookup - Individuals (SALI) Enforcement Data Delivery Standards Small Businesses Appellate Briefs Amicus / Friend of the Court Briefs Home Enforcement and Litigation Litigation Releases William P. Trainor, Vincent D. Celentano, Medical Diagnostic Products, Inc. (f/k/a Novatek International, Inc., Karen Losordo, Diane M. Trainor, Daniel J. Trainor, Geraldine Trainor and Mary N. Celentano William P. Trainor, Vincent D. Celentano, Medical Diagnostic Products, Inc. (f/k/a Novatek International, Inc., Karen Losordo, Diane M. Trainor, Daniel J. Trainor, Geraldine Trainor and Mary N. Celentano Litigation Release No. 17313 / January 15, 2002 Accounting and Auditing Enforcement Release No. 1497 / January 15, 2002 SEC v. William P. Trainor, Vincent D. Celentano, Medical Diagnostic Products, Inc. (f/k/a Novatek International, Inc.), Karen Losordo, Diane M. Trainor, Daniel J. Trainor, Geraldine Trainor and Mary N. Celentano , Civil Action No. 98CV01533 (EGS) (D.D.C.) VINCENT D. CELENTANO ENJOINED IN FRAUD ACTION PAYS $350,000 PENALTY The United States Securities and Exchange Commission ("Commission") today announced that on January 9, 2002, the Honorable Emmet G. Sullivan of the United States District Court for the District of Columbia entered a Final Judgment As To Vincent D. Celentano ("Final Judgment") in the above-captioned civil action. The Commission sued Vincent D. Celentano ("Celentano"), a Hillsboro Beach, Florida resident, for his role in two separate but related frauds concerning the securities of HealthCare, Ltd. ("HealthCare"), a company purportedly based in Russia, and Novatek International, Inc. ("Novatek") of Columbia, Maryland. Celentano consented, without admitting or denying the allegations of the Commission's complaints, to entry of a Final Judgment that i) permanently enjoins him from violating or aiding and abetting the violation of Sections 5(a), 5(c) and 17(a) of the Securities Act of 1933, Sections 10(b), 13(a), 13(b)(2)(A) and (B), 15(a)(1) and 16(a) of the Securities Exchange Act of 1934 and Rules 10b-5, 12b-20, 13a-13, 13b2-1, 13d-1 and 16a-3 promulgated thereunder, ii) permanently bars him from serving as an officer or director of a public company, and iii) orders him to pay a $350,000 civil money penalty. The Commission also dismissed Mary N. Celentano, Celentano's wife, as a relief defendant. On June 18 and August 12, 1998, the Commission filed its complaint and amended complaint ("Complaints"), respectively, against Celentano and others based on their participation in fraudulent "pump and dump" schemes involving the purchase and sale of HealthCare and Novatek securities, both of which claimed to own licenses to distribute medical diagnostic test kits designed to rapidly diagnose HIV, cholera and other diseases. In 1995, HealthCare, a shell company controlled by Celentano and another defendant, raised approximately $2.5 million from investors, primarily friends and family members. HealthCare falsely claimed to have signed contracts worth millions of dollars with Russian governmental entities for the sale of the test kits. The Complaints allege, among other things, that 1) Celentano's offers and sales of HealthCare securities were not registered with the Commission, as required by law; 2) Celentano and others defrauded investors by knowingly making false and misleading statements regarding the existence of the multi-million dollar contracts; and 3) Celentano was not licensed to sell securities, as required by law. In fact, no such contracts ever existed and HealthCare never sold any product for commercial purposes. In 1996, Celentano and others orchestrated a second fraudulent scheme whereby they obtained more than $10 million from investors in connection with sales of Novatek securities. Novatek claimed to own a license to distribute test kits in South and Central America. Through a series of press releases, Novatek stated that it had entered into contracts worth more than $400 million with several South American entities. The purported contracts, however, never existed and Novatek never made any commercial shipments of any test kits. In connection with the Novatek fraud, the Complaints allege, among other things, that 1) Celentano and others artificially inflated the value of Novatek securities through a series of sham transactions; 2) Celentano caused Novatek to file reports with the Commission containing false and misleading financial statements; and 3) Celentano knowingly made false and misleading statements to investors and prospective investors concerning the existence of purported contracts. Additionally, in two related matters, the U.S. Department of Justice has filed criminal charges against Celentano and William P. Trainor in the U. S. District Court for the Southern District of Florida. In United States v. Celentano , 01-6179-CR-WDF, Celentano pleaded guilty to violating 18 U.S.C. §1001 for making a false statement to the Commission and was sentenced by Judge Wilkie D. Ferguson to two years probation and assessed a $5,000 fine. The indictment against Trainor charges him with twenty-one counts of wire fraud and money laundering in violation of 18 U.S.C. §§1345, 1956, 1957 and 2 in United States v. Trainor , 01-6215-CR-Jordan. This matter is still pending. On January 10, 2002, Judge Sullivan entered an order staying the Commission's action against the remaining defendants in the Commission's case, pending the outcome of the criminal proceeding against Trainor. For additional information, see Litigation Release Nos. 15786 and 15844, and Securities Exchange Act of 1934 Release Nos. 40169 , 40170 and 40171 . Return to top SEC homepage About the SEC Budget & Performance Careers Commission Votes Contact Contracts Transparency Accessibility & Disability Super Intelligence FOIA Inspector General No FEAR Act Data Ombuds SEC Excess Personal Property Guidance Websites Investor.gov Related Sites USA.gov Site Information Plain Writing Privacy & Security Site Map Stay connected. Sign up for email updates. Your email address Sign Up X Facebook Instagram RSS YouTube Email Updates
SEC.gov | William P. Trainor, Vincent D. Celentano, Medical Diagnostic Products, Inc. (f/k/a Novatek International, Inc., Karen Losordo, Diane M. Trainor, Daniel J. Trainor, Geraldine Trainor and Mary N. Celentano
!function(){var e=navigator.userAgent,a=document.documentElement,n=a.className;n=n.replace("no-js","js"),/iPad|iPhone|iPod/.test(e)&&!window.MSStream&&(n+=" ua-ios"),a.className=n}();
{"path":{"baseUrl":"\/","pathPrefix":"","currentPath":"node\/487096","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en"},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"gtag":{"tagId":"","consentMode":false,"otherIds":[],"events":[],"additionalConfigInfo":[]},"ajaxPageState":{"libraries":"eJxdT0GOwzAI_JBdn_oei2DkeINNZLC22devlaZS2wtiBhhmcKNUTPo97jxyaXEH3GJpiZrFhQW38A4cMqgeYQGlV19JFTKpQ-kUmvQKXP7I0cO4tC2kPnbg2wVdFslM0SCHPMs3vsEPPD7J6hgOGdPCKJyoRxxqUuePHjLLAuzVjimenRJGSLW08NoBK9LUn6SHlrytVOlcpJShB63QLSpBx_WkOzHNePol4fRQo_qMPvQ36ZXsAmd99lMNr2t_GUR9n60EyX9a_wePd5ns","theme":"uswds_sec","theme_token":null},"ajaxTrustedUrl":[],"gtm":{"tagId":null,"settings":{"data_layer":"dataLayer","include_classes":false,"allowlist_classes":"","blocklist_classes":"","include_environment":false,"environment_id":"","environment_token":""},"tagIds":["GTM-TD3BKV"]},"data":{"extlink":{"extTarget":false,"extTargetAppendNewWindowDisplay":true,"extTargetAppendNewWindowLabel":"(opens in a new window)","extTargetNoOverride":false,"extNofollow":false,"extTitleNoOverride":false,"extNoreferrer":false,"extFollowNoOverride":false,"extClass":"0","extLabel":"(link is external)","extImgClass":false,"extSubdomains":true,"extExclude":".*\\.gov|http:\/\/www.xbrl.org\/utr\/2013-05-17\/utr.xml|http:\/\/www.xbrl.org\/dtr\/type\/numeric-2009-12-16.xsd|http:\/\/www.xbrl.org\/dtr\/type\/nonNumeric-2009-12-16.xsd|https:\/\/secir.secure.force.com\/ombudsman\/OMMSForm","extInclude":"","extCssExclude":".data-exempt","extCssInclude":"","extCssExplicit":"","extAlert":true,"extAlertText":"You are now leaving the SEC Website. The link you have selected is located on another server. Please click on the OK button below to proceed to the selected site. The SEC does not endorse this web site, its sponsor, or any of the policies, activities, products, or services offered on the site or by any advertiser on the site.","extHideIcons":false,"mailtoClass":"0","telClass":"","mailtoLabel":"(link sends email)","telLabel":"(link is a phone number)","extUseFontAwesome":false,"extIconPlacement":"append","extPreventOrphan":false,"extFaLinkClasses":"fa fa-external-link","extFaMailtoClasses":"fa fa-envelope-o","extAdditionalLinkClasses":"","extAdditionalMailtoClasses":"","extAdditionalTelClasses":"","extFaTelClasses":"fa fa-phone","allowedDomains":null,"extExcludeNoreferrer":""}},"user":{"uid":0,"permissionsHash":"e506dfd1572f94bd1f339f1a7483bfbded31d4a9d2bdfdca3fdbc235153380ee"}}
Skip to search field
Skip to main content
An official website of the United States government
Here’s how you know
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock
( Lock A locked padlock )
or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.